Mitsui Chemicals partners with Global Brain Corporation to establish corporate venture capital fund entitled 321FORCE; fund will help accelerate creation of new business and products including health care, mobility, carbon neutrality and more

Sample article from our Sustainability & Social Responsibility

TOKYO , July 5, 2022 (press release) –

Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) has established corporate venture capital (CVC) fund with Global Brain Corporation (CEO: YURIMOTO Yasuhiko), a major independent venture capital company. Established to help accelerate the creation of new businesses and products, the fund has been named 321FORCE™.

Mitsui Chemicals has already been investing in startup companies and venture capital firms as part of its efforts to create new businesses and products. With the recent establishment of 321FORCE™, Mitsui Chemicals will endeavor to further ramp up its sourcing of themes that fit with company strategy, as well as its investment in startups.

Fields for investment are set to span not only those where Mitsui Chemicals can make use of its assets and resources — including the likes of life & healthcare, mobility, ICT, carbon neutrality, digital transformation, smart cities and universe — but also markets and technologies that hold significant potential for future growth.

What is more, Mitsui Chemicals will leverage the activities of 321FORCE™ to match ideas originating in-house with the technologies and businesses of startup companies; improve the accessibility of advanced information; and build a company-wide intelligent platform aimed at having the whole of Mitsui Chemicals come together in the creation of new businesses. Aims through all this are to work toward building solutions-based business models, which represent part of the company’s Basic Strategy for VISION 2030.


Overview of 321FORCE™

Name 321FORCE™
Scale of fund 5 billion yen
Operating period 10 years
Targeted business stage Startups in the seed stage or beyond
Targeted region Global
Fields for investment Industrial sectors including life & healthcare, mobility, ICT, carbon neutrality, digital transformation, smart cities and universe
General partner Global Brain Corporation
Limited partner Mitsui Chemicals, Inc. (Homepage:


Overview of Global Brain Corporation 

Establishment 1998
Head Office Tokyo
Locations U.S., U.K., South Korea, Singapore, Indonesia, China, India
Business Venture capital business
Description A major player in the venture capital industry, Global Brain handles not only basic investment funds but also 11 CVC funds. The company is skilled at unearthing startup companies, and has a long track record of establishing joint CVC funds with the likes of Mitsui Fudosan and KDDI. Focused on boosting the value of the investee while also creating synergy with the investor, Global Brain has met with positive feedback from investees and investors alike. The company manages funds with an emphasis on both financial and strategic returns.


* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order sustainability & social responsibility coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.